BioWorld

Thomson Reuters BioWorld
Biosimilars: A Global Perspective of a New Market - Opportunities, Threats and Critical Strategies 2014: Enterprise
Customers Who Bought This Also Bought
$3,998.00 $7,995.00
Biosimilars: A Global Perspective of a New Market - Opportunities, Threats and Critical Strategies 2014: Single User
Customers Who Bought This Also Bought
$1,998.00 $3,995.00
Showing 1 to 2 of 2 (1 Pages)